Melin Eva O, Svensson Ralph, Gustavsson Sven-Åke, Winberg Agneta, Denward-Olah Ewa, Landin-Olsson Mona, Thulesius Hans O
Department of Clinical Sciences, Endocrinology and Diabetes, Lund University, Lund, Sweden.
Department of Research and Development, Region Kronoberg, Box 1223, SE-351 12, Växjö, Sweden.
Trials. 2016 Apr 27;17(1):221. doi: 10.1186/s13063-016-1347-8.
Depression is linked with alexithymia, anxiety, high HbA1c concentrations, disturbances of cortisol secretion, increased prevalence of diabetes complications and all-cause mortality. The psycho-educational method 'affect school with script analysis' and the mind-body therapy 'basic body awareness treatment' will be trialled in patients with diabetes, high HbA1c concentrations and psychological symptoms. The primary outcome measure is change in symptoms of depression. Secondary outcome measures are changes in HbA1c concentrations, midnight salivary cortisol concentration, symptoms of alexithymia, anxiety, self-image measures, use of antidepressants, incidence of diabetes complications and mortality.
Two studies will be performed. Study I is an open-labeled parallel-group study with a two-arm randomized controlled trial design. Patients are randomized to either affect school with script analysis or to basic body awareness treatment. According to power calculations, 64 persons are required in each intervention arm at the last follow-up session. Patients with type 1 or type 2 diabetes were recruited from one hospital diabetes outpatient clinic in 2009. The trial will be completed in 2016. Study II is a multicentre open-labeled parallel-group three-arm randomized controlled trial. Patients will be randomized to affect school with script analysis, to basic body awareness treatment, or to treatment as usual. Power calculations show that 70 persons are required in each arm at the last follow-up session. Patients with type 2 diabetes will be recruited from primary care. This study will start in 2016 and finish in 2023. For both studies, the inclusion criteria are: HbA1c concentration ≥62.5 mmol/mol; depression, alexithymia, anxiety or a negative self-image; age 18-59 years; and diabetes duration ≥1 year. The exclusion criteria are pregnancy, severe comorbidities, cognitive deficiencies or inadequate Swedish. Depression, anxiety, alexithymia and self-image are assessed using self-report instruments. HbA1c concentration, midnight salivary cortisol concentration, blood pressure, serum lipid concentrations and anthropometrics are measured. Data are collected from computerized medical records and the Swedish national diabetes and causes of death registers.
Whether the "affect school with script analysis" will reduce psychological symptoms, increase emotional awareness and improve diabetes related factors will be tried, and compared to "basic body awareness treatment" and treatment as usual.
ClinicalTrials.gov: NCT01714986.
抑郁症与述情障碍、焦虑、糖化血红蛋白(HbA1c)浓度升高、皮质醇分泌紊乱、糖尿病并发症患病率增加以及全因死亡率相关。将在患有糖尿病、HbA1c浓度高且有心理症状的患者中试验心理教育方法“通过剧本分析影响学校”和身心疗法“基本身体意识治疗”。主要结局指标是抑郁症状的变化。次要结局指标包括HbA1c浓度、午夜唾液皮质醇浓度、述情障碍症状、焦虑、自我形象指标、抗抑郁药的使用、糖尿病并发症的发生率和死亡率的变化。
将进行两项研究。研究I是一项开放标签的平行组研究,采用双臂随机对照试验设计。患者被随机分配到通过剧本分析影响学校组或基本身体意识治疗组。根据功效计算,在最后一次随访时每个干预组需要64人。2009年从一家医院糖尿病门诊招募1型或2型糖尿病患者。该试验将于2016年完成。研究II是一项多中心开放标签的平行组三臂随机对照试验。患者将被随机分配到通过剧本分析影响学校组、基本身体意识治疗组或常规治疗组。功效计算表明,在最后一次随访时每个组需要70人。2型糖尿病患者将从初级保健机构招募。这项研究将于2016年开始并于2023年结束。对于两项研究,纳入标准为:HbA1c浓度≥62.5 mmol/mol;抑郁、述情障碍、焦虑或负面自我形象;年龄18 - 59岁;糖尿病病程≥1年。排除标准为妊娠、严重合并症、认知缺陷或瑞典语能力不足。使用自我报告工具评估抑郁、焦虑、述情障碍和自我形象。测量HbA1c浓度、午夜唾液皮质醇浓度、血压、血脂浓度和人体测量指标。数据从计算机化医疗记录以及瑞典国家糖尿病和死亡原因登记处收集。
将尝试“通过剧本分析影响学校”是否会减轻心理症状、提高情绪意识并改善糖尿病相关因素,并与“基本身体意识治疗”和常规治疗进行比较。
ClinicalTrials.gov:NCT01714986。